Ibnsina Pharma (EGX:ISPH)

Market Cap	12.05B +24.7%
Revenue (ttm)	76.60B +37.2%
Net Income	771.11M +54.9%
EPS	0.76 +54.9%
Shares Out	1.01B
PE Ratio	15.62
Forward PE	7.81
Dividend	0.16 (1.34%)
Ex-Dividend Date	Apr 27, 2026

Volume	9,388,592
Average Volume	12,010,011
Open	11.95
Previous Close	11.95
Day's Range	11.65 - 12.04
52-Week Range	8.17 - 13.72
Beta	0.70
RSI	62.72
Earnings Date	May 20, 2026

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistics services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as telesales and promotion services. The company was founded in 2001 and is headquartered in El Obour City...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2025, Ibnsina Pharma's revenue was 76.60 billion, an increase of 37.17% compared to the previous year's 55.84 billion. Earnings were 771.11 million, an increase of 54.90%.